
Last Price
52 Week Range
$0.63 - $5.14
Next Earnings Date
Feb 11 2026 (Estimate)
Next Earnings Date
Feb 11 2026 (Est.)
Last Price
Company Name | Form Type | Filed | View |
|---|---|---|---|
Vistagen Therapeutics, Inc. | 8-K | January 9, 2026 | |
Vistagen Therapeutics, Inc. | 8-K | December 22, 2025 | |
Vistagen Therapeutics, Inc. | 8-K | December 3, 2025 | |
Vistagen Therapeutics, Inc. | 10-Q | November 13, 2025 | |
Vistagen Therapeutics, Inc. | 8-K | November 13, 2025 | |
Vistagen Therapeutics, Inc. | 8-K | November 4, 2025 | |
Vistagen Therapeutics, Inc. | 8-K | October 29, 2025 | |
Vistagen Therapeutics, Inc. | 8-K | September 15, 2025 | |
Vistagen Therapeutics, Inc. | 8-K | August 7, 2025 | |
Vistagen Therapeutics, Inc. | 10-Q | August 7, 2025 | |
Vistagen Therapeutics, Inc. | DEF 14A | July 28, 2025 | |
Vistagen Therapeutics, Inc. | DEFA14A | July 28, 2025 | |
Vistagen Therapeutics, Inc. | 8-K | June 25, 2025 | |
Vistagen Therapeutics, Inc. | 8-K | June 17, 2025 | |
Vistagen Therapeutics, Inc. | 10-K | June 17, 2025 | |
Vistagen Therapeutics, Inc. | 8-K | June 2, 2025 | |
Vistagen Therapeutics, Inc. | 8-K | March 6, 2025 | |
Vistagen Therapeutics, Inc. | 8-K | February 13, 2025 | |
Vistagen Therapeutics, Inc. | 10-Q | February 13, 2025 | |
Vistagen Therapeutics, Inc. | 8-K | February 5, 2025 | |
Vistagen Therapeutics, Inc. | 8-K | January 14, 2025 | |
Vistagen Therapeutics, Inc. | 8-K | January 13, 2025 | |
Vistagen Therapeutics, Inc. | 8-K | December 6, 2024 | |
Vistagen Therapeutics, Inc. | 10-Q | November 7, 2024 | |
Vistagen Therapeutics, Inc. | 8-K | November 7, 2024 | |
Vistagen Therapeutics, Inc. | 8-K | September 23, 2024 | |
Vistagen Therapeutics, Inc. | 8-K | August 28, 2024 | |
Vistagen Therapeutics, Inc. | 8-K | August 13, 2024 | |
Vistagen Therapeutics, Inc. | 10-Q | August 13, 2024 | |
Vistagen Therapeutics, Inc. | DEF 14A | July 17, 2024 |
Market data is sourced from S&P Global Market Intelligence. All insights and analysis are developed by Gainify. Copyright © 2026, S&P Global Market Intelligence. All rights reserved.
View Data ProvidersNEWSLETTER
Market data is sourced from S&P Global Market Intelligence. All insights and analysis are developed by Gainify. Copyright © 2026, S&P Global Market Intelligence. All rights reserved.
View Data ProvidersGainify provides tools and content designed to help users explore and understand the world of investing. All information available through our platform is for educational and informational use only. It is not intended as financial, investment or legal advice, and should not be treated as a recommendation or endorsement of any investment approach.
Our content is general in nature and does not account for your personal financial circumstances. Any investment decisions you make are your responsibility. We strongly recommend speaking with a licensed financial advisor or professional before acting on any information found on Gainify. Before using Gainify, please review our Terms of Service.